Mergers & Acquisitions - Shire

Filter

Current filters:

Shire

Popular Filters

176 to 200 of 906 results

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

Savient files for voluntary bankruptcy protection; plans asset sale

15-10-2013

US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

15-10-2013

AstraZeneca revealed this morning that its biologics subsidiary MedImmune has acquired Spirogen, a privately-held…

ADC TherapeuticsAstraZenecaMedImmuneMergers & AcquisitionsOncologyPharmaceuticalSpirogen

Akorn buy of Hi-Tech Pharmacal delayed by FTC request

13-10-2013

In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Vivaldi Biosciences acquires clinical stage influenza vaccine assets

13-10-2013

Privately-held US biotech firm Vivaldi Biosciences has acquired from Baxter Healthcare R&D assets, including…

Anti-viralsBaxter HealthcareBaxter InternationalBiotechnologyMergers & AcquisitionsVaccinesVivaldi Biosciences

Osiris to sell culture-expanded MSCs business including Prochymal

11-10-2013

USA-based Osiris Therapeutics has entered into an agreement with a wholly-owned subsidiary of Mesoblast…

BiotechnologyFinancialMergers & AcquisitionsMesoblastOsiris TherapeuticsProchymal

OPKO makes strategic investment in biotech firm

11-10-2013

US pharma and diagnostics firm OPKO Health has agreed to make an undisclosed strategic investment in…

BiotechnologyMergers & AcquisitionsOPKO HealthPharmaceuticalZebra Biologics

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

09-10-2013

PharmAkea Therapeutics and Bay City Capital have entered a strategic collaboration with Celgene designed…

BiotechnologyCelgeneMergers & AcquisitionsNorth AmericaOncologyPharmAkeaResearch

Astellas links with Mitokyne on mitochondria-related therapies

Astellas links with Mitokyne on mitochondria-related therapies

07-10-2013

Japanese drug major Astellas Pharma and USA-based start-up Mitokyne have entered into an exclusive R&D…

Astellas PharmaFinancialLicensingMergers & AcquisitionsMitokynePharmaceuticalResearch

BTG ups full year guidance following acquisitions

03-10-2013

UK specialist health care company BTG has provided an update for the six months ended September 30, 2013,…

BTGFinancialMergers & AcquisitionsPharmaceutical

Astex urges stockholders to tender shares into Otsuka offer

03-10-2013

The board of directors of USA-based Astex Pharmaceuticalsissued a letter to stockholders addressing what…

Astex PharmaceuticalsMergers & AcquisitionsOtsukaPharmaceutical

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

France’s Servier offers to take full control of Egis Pharma

France’s Servier offers to take full control of Egis Pharma

25-09-2013

French privately-held drugmaker Servier has made a voluntary public offer to buy all outstanding shares…

EGIS PharmaceuticalsEuropeMergers & AcquisitionsPharmaceuticalServier

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

20-09-2013

USA-based Retrophin (OTCQB: RTRX) has made a proposal to the board of directors of Transcept Pharmaceuticals…

Mergers & AcquisitionsPharmaceuticalRetrophinTranscept Pharma

First-half 2013 sees fall in licensing, says Evaluate

20-09-2013

Despite a positive start to the year characterized by healthy initial public offering (IPO) activity…

FinancialLicensingMergers & AcquisitionsPharmaceutical

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

UK's BTG sells brachytherapy business for $5million

UK's BTG sells brachytherapy business for $5million

17-09-2013

UK-based specialty pharma company BTG (LSE: BTG) has sold its brachytherapy business to German company…

BTGEuropeMergers & AcquisitionsPharmaceutical

Chiesi Farmaceutici to acquire full ownership of Cornerstone Therapeutics

17-09-2013

Privately-held Italian drugmaker Chiesi Farmaceutici and specialty US firm Cornerstone Therapeutics (Nasdaq:…

Chiesi FarmaceuticiCornerstone TherapeuticsMergers & AcquisitionsPharmaceutical

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Cellceutix acquires PolyMedix assets from bankruptcy court

09-09-2013

US clinical-stage biopharma firm Cellceutix (OTCBB: CTIX) has acquired substantially all of the assets…

BiotechnologybrilacidinCellceutixMergers & AcquisitionsPharmaceuticalPolyMedixPrurisol

176 to 200 of 906 results

Back to top